The effects of tolazoline, nitroprusside, nitroglycerin, isoproterenol and hydralazine on pulmonary circulation early after heart valve replacement.
D000368:Aged; D005260:Female; D005292:Ferricyanides / Q000627:therapeutic use*; D006350:Heart Valve Prosthesis; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D007545:Isoproterenol / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000627:therapeutic use*; D009599:Nitroprusside / Q000627:therapeutic use*; D011182:Postoperative Care; D011652:Pulmonary Circulation / Q000187:drug effects*; D011667:Pulmonary Veins / Q000187:drug effects; D014043:Tolazoline / Q000627:therapeutic use*; D014655:Vascular Resistance / Q000187:drug effects
D005292:Ferricyanides; D009599:Nitroprusside; D006830:Hydralazine; D014043:Tolazoline; D005996:Nitroglycerin; D007545:Isoproterenol